Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma
Clinical trial NCT00033709 · UNKNOWN
Trial details
- NCT number
- NCT00033709
- Sponsor
- Herbert Irving Comprehensive Cancer Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.